[Federal Register Volume 66, Number 71 (Thursday, April 12, 2001)]
[Notices]
[Pages 18937-18938]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-9012]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Notice of Meeting: Secretary's Advisory Committee on Genetic 
Testing

    Pursuant to Public Law 92-463, notice is hereby given of the ninth 
meeting of the Secretary's Advisory Committee on Genetic Testing 
(SACGT), U.S. Public Health Service. The meeting will be held from 9:00 
a.m. to 5:00 p.m. on May 2, 2001 and 8:30 a.m. to 3:00 p.m. on May 3, 
2001 at the National Institutes of Health, Building 31, C Wing, 
Conference Room 10, 9000 Rockville Pike, Bethesda, MD 20892. The 
meeting will be open to the public with attendance limited to space 
available.
    The Committee will discuss a number of topics, including continuing 
FDA activities to develop a review template for genetic tests and FDA's 
labeling authorities as they pertain to genetic tests, as well as 
interagency progress on the development of coordinated genetic testing 
information systems. The Committee will begin exploring best practices 
in the development of clinical guidelines for genetic testing and hear 
progress reports from the Committee's work groups. There will be time 
provided for public comment and interested individuals should notify 
the contact person listed below. The Committee is particularly 
interested in hearing from members of the public about FDA's draft 
review template for genetic tests. Copies of the draft template can be 
obtained from SACGT staff listed below.
    Under authority of 42 U.S.C. 217(a), Section 222 of the Public 
Health Service Act, as amended, the Department of Health and Human 
Services established SACGT to advise and make recommendations to the 
Secretary through the Assistant Secretary for Health on all aspects of 
the development and use of genetic tests.

[[Page 18938]]

The SACGT is directed to (1) recommend policies and procedures for the 
safe and effective incorporation of genetic technologies into health 
care; (2) assess the effectiveness of existing and future measures for 
oversight of genetic tests; and (3) identify research needs related to 
the Committee's purview.
    The draft meeting agenda and other information about SACGT will be 
available at the following web site: http://www4.od.nih.gov/oba/sacgt.htm. Individuals who wish to provide public comments or who plan 
to attend the meeting and need special assistance, such as sign 
language interpretation or other reasonable accommodations, should 
notify the SACGT Executive Secretary, Ms. Sarah Carr, by telephone at 
301-496-9838 or E-mail at [email protected]. The SACGT office is located 
at 6705 Rockledge Drive, Suite 750, Bethesda, Maryland 20892.

    Dated: April 4, 2001.
Sarah Carr,
Executive Secretary, SACGT.
[FR Doc. 01-9012 Filed 4-11-01; 8:45 am]
BILLING CODE 4140-01-M